Markets:

Overview

News

Currencies

International

Treasuries

INVESCO Ltd (NY:IVZ)

30.05 -0.38 (-1.27%)

Streaming Delayed Price Updated: 12:13 PM EDT, Sep 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about INVESCO Ltd

< Previous 1 2 3 4 5 6 7 8 9

...

86 87 Next >

PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗

September 15, 2026

PBE offers higher income and stronger returns, while RSPH provides broader diversification with lower costs and drawdown risk.

Via The Motley Fool

Topics ETFs

SpaceX Defies Gravity With a Nasdaq-100 Double-Weighting Boost ↗

September 15, 2026

SpaceX's Nasdaq-100 weighting will more than double at the Sept. 18 rebalance as lockup expirations expand its float, forcing index funds to buy billions in shares.

Via MarketBeat

Better Clean Energy ETF: Broad Exposure Through iShares' ICLN vs. Invesco's Solar-Focused TAN ↗

September 14, 2026

One fund concentrates on solar alone, while the other diversifies across wind and other renewables. Which strategy aligns with your risk tolerance?

Via The Motley Fool

Topics ETFs

INVESCO LTD (NYSE:IVZ) Shows Strong Trend Template and High Growth Momentum Setup ↗

September 09, 2026

Via Chartmill

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. ↗

September 11, 2026

PPH offers concentrated pharma exposure with 1.9% yield and lower volatility, while RSPH provides broader diversification across 60 healthcare holdings.

Via The Motley Fool

Topics ETFs

The S&P 500 Is Doing Something It Hasn't Done in Decades. This ETF Could Be the Smarter Buy Right Now. ↗

September 11, 2026

The market remains historically concentrated in tech, but the broader rotation away from that sector continues.

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

3 Reasons to Sell IVZ and 1 Stock to Buy Instead

September 11, 2026

Invesco’s 33.6% return over the past six months has outpaced the S&P 500 by 20.8%, and its stock price has climbed to $31.99 per share. This was partly thank...

Via StockStory

Topics Artificial Intelligence Stocks

2 Momentum Stocks with Competitive Advantages and 1 We Ignore

September 10, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...

Via StockStory

iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? ↗

September 09, 2026

Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns.

Via The Motley Fool

Topics ETFs

What Is an ETF? I Think It's the Single Best Starting Point for New Investors. ↗

September 09, 2026

VOO and QQQM provide instant diversification and long-term safety.

Via The Motley Fool

Topics ETFs Stocks

Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund? ↗

September 08, 2026

IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too.

Via The Motley Fool

Topics ETFs

Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits ↗

September 08, 2026

Invesco's concentrated 30-stock pharma fund delivered 43.1% returns last year, but iShares' broader 100-holding portfolio costs less and offers wider sector exposure.

Via The Motley Fool

Topics ETFs

This ETF Would Have Increased Your Investment by 6x Over the Past 10 Years -- and It's Still Soaring ↗

September 07, 2026

High-growth holdings have driven this fund's success.

Via The Motley Fool

Topics Artificial Intelligence ETFs

Is This the Smartest ETF to Buy and Hold in 2026? Here's What History Suggests. ↗

September 06, 2026

It has outperformed the S&P 500 and the Nasdaq 100 over the past five years.

Via The Motley Fool

Topics ETFs Stocks

Insiders and Early Investors Are Selling SpaceX Stock and Index Funds Are Buying It. Which Side Do You Want to Be On? ↗

September 05, 2026

Could IPO lockup expirations create buying opportunities for long-term investors?

Via The Motley Fool

Topics ETFs Initial Public Offering Regulatory Compliance

If I Were in My 20s, I'd Buy This Spectacular Nasdaq-100 Index Fund and Hold It Forever ↗

September 04, 2026

Investors who focus on growth in their younger years could build significant wealth by the time they reach retirement.

Via The Motley Fool

Topics Artificial Intelligence ETFs Supply Chain

3 Stocks Under $50 We Keep Off Our Radar

September 03, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ ↗

September 02, 2026

Invesco's biotech fund surged 56.4% in one year, while Fidelity's broader healthcare portfolio offers lower costs and steadier returns.

Via The Motley Fool

Topics ETFs

Invesco KBW Bank ETF Wins on Yield and 1-Year Return. Is It a Better Financials Fund Than IYF? ↗

September 02, 2026

KBWB concentrates on 26 banking stocks with higher yield, while IYF diversifies across more than 140 financial firms with lower volatility.

Via The Motley Fool

Topics ETFs

Stock Market Today, Sept. 1: Stocks Slide and Oil Surges Amid U.S.-Iran Tension ↗

September 01, 2026

On Sept. 1, 2026, rising crude and Treasury yields pressured equities across nearly every sector, with tech stocks bearing the brunt of the selloff.

Via The Motley Fool

Topics ETFs Stocks

Prediction: If a September Sell-Off Hits Speculative AI Stocks, Quantum Computing Falls First ↗

September 01, 2026

Quantum computing stocks may drop dramatically if investors decide they've been paying too much for hoped-for future growth.

Via The Motley Fool

Topics Artificial Intelligence Economy

QUICK SPARK: Invesco’s RSP Hits $100 Billion as Equal-Weight ETFs Gain Ground ↗

September 01, 2026

Invesco’s RSP ETF hits $100 billion in AUM as investors seek equal-weight exposure to reduce reliance on mega-cap S&P 500 stocks.

Via Benzinga

Topics ETFs Stocks

Cash Pays, but It Doesn't Grow: Why Advisors Still Favor Dividend ETFs for Retirees ↗

September 01, 2026

Cash only feels safe when you forget about the destructive impact of inflation.

Via The Motley Fool

Topics ETFs Economy Retirement

This Unstoppable ETF Could Turn $100 per Month Into $40,000 With Next to No Effort on Your Part. Here's How. ↗

August 31, 2026

Committed set-it-and-forget-it investors would do well to consider the long-term potential of the Invesco NASDAQ 100 ETF.

Via The Motley Fool

Topics Artificial Intelligence ETFs

This 2 ETF Portfolio Historically Outperforms the S&P 500 With Less Volatility ↗

August 30, 2026

Combining two factors that produce strong returns may be all you need.

Via The Motley Fool

Topics ETFs Stocks

VOO vs. RSP: If AI Stocks Get Too Concentrated, Here's Which One I'd Choose ↗

August 30, 2026

These ETFs both hold S&P 500 members but with very different allocations.

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

If You'd Invested $1,000 in QQQ 20 Years Ago, Here's What You'd Have Today ↗

August 29, 2026

Your investment would have grown substantially, but only if you exercised discipline and patience.

Via The Motley Fool

Topics ETFs

Better Growth Stock ETF: Vanguard's Large-Cap VUG vs. Invesco's Small-Cap RZG ↗

August 29, 2026

VUG delivered 80% higher five-year returns despite a 10x higher expense ratio, but RZG surged 26.9% over the past year.

Via The Motley Fool

Topics ETFs

What I Learned From Investing Through 3 Big Stock Market Crashes ↗

August 28, 2026

The stock market has recovered from the biggest crashes. Crises end, but the world keeps going.

Via The Motley Fool

Topics Artificial Intelligence Bankruptcy ETFs

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? ↗

August 28, 2026

VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.

Via The Motley Fool

Topics ETFs

< Previous 1 2 3 4 5 6 7 8 9

...

86 87 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.